Accent Therapeutics - Raised $178M Funding from 12 investors

Oct 27, 2024  · Accent Therapeutics has raised a total funding of $178M over 3 rounds from 12 investors. Investors include Atlas Venture, Google Ventures and 10 others. Their latest funding …


Install CouponFollow Chrome Extension   CouponFollow Extension

$178
OFF

Accent Therapeutics - Raised $178M Funding From 12 Investors

6 days from now

Oct 27, 2024  · Accent Therapeutics has raised a total funding of $178M over 3 rounds from 12 investors. Investors include Atlas Venture, Google Ventures and 10 others. Their latest funding …

tracxn.com

$178
OFF

Accent Therapeutics Company Profile 2024: Valuation, Funding ...

6 days from now

Accent Therapeutics has raised $178M. Who are Accent Therapeutics’s investors? Bristol-Myers Squibb, Johnson & Johnson Innovation - JJDC, Mirae Asset Capital, Mirae Asset Capital Life …

pitchbook.com

$178
OFF

Accent Therapeutics - Company Profile - Tracxn

6 days from now

Oct 27, 2024  · Accent Therapeutics - Developer of small molecule based therapeutics for cancer treatment. Raised a total funding of $178M over 3 rounds from 12 investors. Founded by …

tracxn.com

$178
OFF

Accent Therapeutics Stock Price, Funding, Valuation, Revenue ...

6 days from now

Jan 23, 2024  · Accent Therapeutics has raised $178M over 3 rounds. Accent Therapeutics's latest funding round was a Series C for $75M on January 23, 2024. Date. Round. Amount. ... First …

cbinsights.com

$178
OFF

Accent Therapeutics - Products, Competitors, Financials, …

6 days from now

Accent Therapeutics's latest funding round is Series C. How much did Accent Therapeutics raise? Accent Therapeutics raised a total of $178M. ... Investors of Accent Therapeutics include The …

cbinsights.com

$178
OFF

Accent Therapeutics (USA) Funding: $178M - Medical Startups

6 days from now

3 days ago  · Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology …

medicalstartups.org

$75000000
OFF

Series C - Accent Therapeutics - 2024-01-23 - Crunchbase

6 days from now

Jan 23, 2024  · Accent Therapeutics raised $75000000 on 2024-01-23 in Series C. ... Organization Name . Accent Therapeutics . Announced Date Jan 23, 2024; Closed On Date Jan 23, 2024; …

crunchbase.com

$75
OFF

Accent Therapeutics Announces $75 Million Series C Financing To …

6 days from now

Jan 23, 2024  · Financing led by Mirae Asset Capital Life Science with participation from additional new and existing investors. Funds will support advancement of lead programs through early …

prnewswire.com

$75
OFF

Accent Therapeutics Announces $75 Million Series C Financing To …

6 days from now

Jan 23, 2024  · Accent Therapeutics, a biopharmaceutical company pioneering a new class of small molecule precision cancer therapies, today announced the completion of a $75 million …

yahoo.com

$75
OFF

Accent Therapeutics Secures Funding To Advance Cancer Therapies

6 days from now

Jan 24, 2024  · Accent Therapeutics has announced the successful completion of a $75m Series C financing round to progress the development of small molecule precision cancer therapies. …

pharmaceutical-technology.com

$75
OFF

Pharmas Back Accent’s Plan To Make RNA-targeting Cancer Drugs

6 days from now

Jan 23, 2024  · Accent Therapeutics has raised a $75 million Series C round, the company announced Tuesday in a sign of continued investor interest in chemical drugs that target RNA …

biopharmadive.com

$75
OFF

Accent Therapeutics Raises $75M In Series C Funding Round

6 days from now

Jan 23, 2024. Biopharmaceutical company Accent Therapeutics has raised $75 million in a series C financing round, with the aim of using the funds to advance two of its precision oncology …

labpulse.com

$75
OFF

Accent Therapeutics Raises $75M In Series C Funding - FinSMEs

6 days from now

Jan 23, 2024  · Accent Therapeutics, a Lexington, MA-based biopharmaceutical company focused on small molecule precision cancer therapies, raised $75M in Series C funding.. The round …

finsmes.com

$102
OFF

Synnovation’s $102m Round Heads Latest Biotech Financings

6 days from now

2 days ago  · RNA specialist Accent Therapeutics has continued a healthy series of funding rounds, raising $75 million in a Series C that was led by Mirae Asset Capital Life Science and …

pharmaphorum.com

$75
OFF

Accent Therapeutics Raises $75M In Series C Funding Round

6 days from now

Jan 23, 2024  · NEW YORK – Accent Therapeutics on Tuesday announced it has raised $75 million in a Series C financing round, and that it will put the funds toward advancing its …

precisionmedicineonline.com

FAQs about Accent Therapeutics - Raised $178M Funding from 12 investors Coupon?

Did Accent Therapeutics raise $75 million in a series C?

RNA specialist Accent Therapeutics has continued a healthy series of funding rounds, raising $75 million in a Series C that was led by Mirae Asset Capital Life Science and supported by Bristol Myers Squibb and Johnson & Johnson’s venture capital arm, as well as existing investors including AbbVie Ventures. ...

Does Accent Therapeutics have a series C financing?

1.23.24 Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies Financing led by Mirae Asset Capital Life Science with participation from additional new and existing investors ...

Is Accent Therapeutics growing?

Accent Therapeutics may be growing as evidenced by the successful closure of a $75 million Series C financing round. This substantial capital infusion suggests that investors have confidence in the company's potential and may enable further research, development, and expansion of operations. ...

When did Accent Therapeutics close?

Accent Therapeutics closed its last funding round on Jan 23, 2024 from a Series C round. Who are Accent Therapeutics's competitors? Alternatives and possible competitors to Accent Therapeutics may include Tessera Therapeutics , Soleno Therapeutics , and Zomedica. ...

Is Accent Therapeutics a biopharmaceutical company?

Accent Therapeutics is a biopharmaceutical company. Is Accent Therapeutics experiencing growth? Accent Therapeutics may be growing as evidenced by the successful closure of a $75 million Series C financing round. ...

Where is Accent Therapeutics headquarters?

Accent Therapeutics's headquarters is located at 1050 Waltham Street, Lexington. What is Accent Therapeutics's latest funding round? ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension